Enorama Pharma AB (ERMA) — Net Asset Quality Index
Enorama Pharma AB (ERMA) has a Net Asset Quality Index of -283.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr8.26 Million minus total liabilities of Skr31.71 Million yields net assets of Skr-23.45 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore ERMA total asset value for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Enorama Pharma AB Net Asset Quality Index Over Time (2014–2025)
This chart shows how Enorama Pharma AB's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the index stands at -283.8%, representing net assets of Skr-23.45 Million against total assets of Skr8.26 Million SEK. See Enorama Pharma AB short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Enorama Pharma AB (2014–2025)
The table below presents the year-by-year Net Asset Quality Index for Enorama Pharma AB from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Enorama Pharma AB (ERMA) total market value.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -283.8% | Skr-23.45 Million | Skr8.26 Million | Skr31.71 Million | ▼ -332.9 pp |
| 2024 | 49.1% | Skr7.80 Million | Skr15.89 Million | Skr8.09 Million | ▼ -7.7 pp |
| 2023 | 56.8% | Skr19.54 Million | Skr34.38 Million | Skr14.85 Million | ▼ -7.9 pp |
| 2022 | 64.7% | Skr31.52 Million | Skr48.72 Million | Skr17.20 Million | ▲ +22.8 pp |
| 2021 | 41.9% | Skr21.35 Million | Skr50.93 Million | Skr29.58 Million | ▲ +37.6 pp |
| 2020 | 4.3% | Skr1.78 Million | Skr40.91 Million | Skr39.13 Million | ▼ -12.5 pp |
| 2019 | 16.9% | Skr7.18 Million | Skr42.58 Million | Skr35.40 Million | ▼ -27.0 pp |
| 2018 | 43.8% | Skr17.02 Million | Skr38.83 Million | Skr21.81 Million | ▼ -3.7 pp |
| 2017 | 47.5% | Skr7.36 Million | Skr15.49 Million | Skr8.13 Million | ▼ -19.1 pp |
| 2016 | 66.6% | Skr9.08 Million | Skr13.63 Million | Skr4.55 Million | ▼ -4.5 pp |
| 2015 | 71.2% | Skr6.52 Million | Skr9.17 Million | Skr2.64 Million | ▼ -0.8 pp |
| 2014 | 72.0% | Skr2.66 Million | Skr3.69 Million | Skr1.03 Million | — |